Operator of a biopharmaceutical company. The company is engaged in the development and commercialization of cancer therapies. Its therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Hengrui Therapeutics‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Adam Zong Ph.D | President & Chief Executive Officer |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Hengrui Therapeutics‘s full profile, request access.
Request a free trial